Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Membranous Nephropathy
NCT00050713Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Dec 2002
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in idiopathic membranous nephropathy (IMN), membranous lupus nephritis (MLN), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Dec 2002; status: completed.
02
Drugs
sirolimus
03
Conditions
idiopathic membranous nephropathy (IMN)membranous lupus nephritis (MLN)
Beyond the preview
Go deeper on NCT00050713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050713.